Latest Headlines
New Warnings for MS Drug Gilenya After FDA Review
Novartis, the maker of the drug Gilenya (fingolimod), a once-daily oral capsule taken for multiple sclerosis, has added stronger warnings to labels and prescription information about the drug’s possible heart risks, according to a company statement.
Novartis, the maker of the drug Gilenya (fingolimod), a once-daily oral capsule taken for multiple sclerosis, has added stronger warnings to labels and prescription information about the drug’s possible heart risks, according to a company statement.
Top Stories
WebMD Multiple Sclerosis Community
Community. Experts. Support.
Top Search Terms for Multiple Sclerosis
1
2
3
4
5
6
Multiple Sclerosis: Recognizing Multiple Sclerosis
Multiple sclerosis symptoms generally appear between the ages of 20 and 40. Typically a person is seen after developing two or more distinct episodes of symptoms that resolve yet are consistent with MS.
Common and Uncommon Symptoms of MS
The most common early symptoms of MS include:
1
2
3
4
5
6
Related to Multiple Sclerosis
Today in Multiple Sclerosis
WebMD Special Sections
Health Solutions From Our Sponsors
Advertise With Us|WebMD Corporate|Medscape Reference|eMedicineHealth|RxList|Medscape|MedicineNet|BootsWebMD
©2005-2012 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.